Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis Vaccines
Research data from K. Katoch and colleagues update understanding of tuberculosis vaccines
April 16th, 2008
Current study results from the report, 'Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis,' have been published. According to a study from Agra, India, "Mycobacterium w (Mw), is a cultivable, non-pathogenic mycobacterium and has been tried extensively as an immunomodulator in leprosy. This has been found to be safe and has shown beneficial immunoprophylactic effect in population based, double blind placebo controlled trials in North India." "These effects were also observed in the vaccine trials in South India. Keeping in view these beneficial effects and its earlier reported protective effect against tuberculosis in animals, its protective...
Source: Vaccine Weekly (2008-04-16)
|
